JP2004532197A5 - - Google Patents

Download PDF

Info

Publication number
JP2004532197A5
JP2004532197A5 JP2002571529A JP2002571529A JP2004532197A5 JP 2004532197 A5 JP2004532197 A5 JP 2004532197A5 JP 2002571529 A JP2002571529 A JP 2002571529A JP 2002571529 A JP2002571529 A JP 2002571529A JP 2004532197 A5 JP2004532197 A5 JP 2004532197A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002571529A
Other versions
JP2004532197A (ja
JP4430305B2 (ja
Filing date
Publication date
Priority claimed from GBGB0106315.5A external-priority patent/GB0106315D0/en
Application filed filed Critical
Publication of JP2004532197A publication Critical patent/JP2004532197A/ja
Publication of JP2004532197A5 publication Critical patent/JP2004532197A5/ja
Application granted granted Critical
Publication of JP4430305B2 publication Critical patent/JP4430305B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002571529A 2001-03-14 2002-03-14 トランスフェクション複合体 Expired - Fee Related JP4430305B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0106315.5A GB0106315D0 (en) 2001-03-14 2001-03-14 Transfection complexes
PCT/GB2002/001215 WO2002072616A2 (en) 2001-03-14 2002-03-14 Transfection complexes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008288941A Division JP2009131255A (ja) 2001-03-14 2008-11-11 トランスフェクション複合体

Publications (3)

Publication Number Publication Date
JP2004532197A JP2004532197A (ja) 2004-10-21
JP2004532197A5 true JP2004532197A5 (ja) 2005-08-04
JP4430305B2 JP4430305B2 (ja) 2010-03-10

Family

ID=9910674

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002571529A Expired - Fee Related JP4430305B2 (ja) 2001-03-14 2002-03-14 トランスフェクション複合体
JP2008288941A Withdrawn JP2009131255A (ja) 2001-03-14 2008-11-11 トランスフェクション複合体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008288941A Withdrawn JP2009131255A (ja) 2001-03-14 2008-11-11 トランスフェクション複合体

Country Status (9)

Country Link
US (3) US7256043B2 (ja)
EP (2) EP1964849B1 (ja)
JP (2) JP4430305B2 (ja)
AT (2) ATE412004T1 (ja)
AU (1) AU2002246226A1 (ja)
CA (1) CA2470152A1 (ja)
DE (1) DE60229499D1 (ja)
GB (1) GB0106315D0 (ja)
WO (1) WO2002072616A2 (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0313132D0 (en) 2003-06-06 2003-07-09 Ich Productions Ltd Peptide ligands
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
US8133733B2 (en) 2003-10-24 2012-03-13 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissues
WO2005056752A2 (en) 2003-10-24 2005-06-23 Gencia Corporation Methods and compositions for delivering polynucleotides
US20090208478A1 (en) * 2003-10-24 2009-08-20 Gencia Corporation Transducible polypeptides for modifying metabolism
US20090123468A1 (en) 2003-10-24 2009-05-14 Gencia Corporation Transducible polypeptides for modifying metabolism
US8507277B2 (en) 2003-10-24 2013-08-13 Gencia Corporation Nonviral vectors for delivering polynucleotides
JP2007043972A (ja) * 2005-08-10 2007-02-22 Tokyo Institute Of Technology アパタイト粒子及びその作製方法、遺伝子−アパタイト粒子複合体及びその作製方法、並びに遺伝子導入方法及び遺伝子導入用キット
BRPI1012919B8 (pt) * 2009-05-29 2022-09-20 Panasonic Corp Aparelho terminal, aparelho de estação base, método para transmitir um sinal a partir de um aparelho terminal, método para receber um sinal transmitido a partir de um aparelho terminal, circuito integrado para controlar um processo em um aparelho terminal e circuito integrado para controlar um processo em uma estação base se comunicando com um aparelho terminal
WO2011105520A1 (ja) 2010-02-26 2011-09-01 国立大学法人 長崎大学 抗原または薬物送達複合体
EP3079723B1 (en) * 2013-12-12 2020-05-27 Life Technologies Corporation Membrane-penetrating peptides to enhance transfection and compositions and methods for using same
LT3341027T (lt) 2015-08-28 2024-06-25 Molecular Transfer, Inc. Transfekcijos kompleksai ir jų panaudojimo būdai
WO2017151733A1 (en) 2016-03-01 2017-09-08 Molecular Transfer, Inc. Plant virus movement proteins and methods of using the same
GB201604235D0 (en) 2016-03-11 2016-04-27 Ucl Business Plc Lipids and complexes for the delivery of biologically-active material to cells
TW201936201A (zh) 2017-12-14 2019-09-16 美商堅固生物科技公司 基因之非病毒生產及遞送
GB201800370D0 (en) 2018-01-10 2018-02-21 Ucl Business Plc Anionic nanocomplexes for nucleic acid delivery
GB201803419D0 (en) * 2018-03-02 2018-04-18 Ucl Business Plc Complex for the delivery of cas9 proteins guide RNA to cells
WO2023006985A1 (en) 2021-07-30 2023-02-02 4Basebio Uk Ltd Nanoparticles and peptides for the delivery of cargos to muscle cells
EP4124345A1 (en) 2021-07-30 2023-02-01 4basebio UK Ltd Nanoparticles for muscle delivery
EP4311559A1 (en) 2022-07-29 2024-01-31 4basebio UK Ltd Nanoparticles and peptides for the delivery of cargos to chondrocytes

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051429A (en) * 1995-06-07 2000-04-18 Life Technologies, Inc. Peptide-enhanced cationic lipid transfections
US6344436B1 (en) * 1996-01-08 2002-02-05 Baylor College Of Medicine Lipophilic peptides for macromolecule delivery
US5923664A (en) * 1996-03-28 1999-07-13 International Business Machines Corporation Method and apparatus providing a multiport physical interface to high speed packet networks
DE69736692T2 (de) 1996-07-16 2007-06-14 Archibald James Mixson Kationisches Vehikel: DNS Komplexe und ihre Verwendung in Gentherapie
GB9711115D0 (en) * 1997-05-29 1997-07-23 Inst Of Child Health Integrin-targeting vectors having enhanced transfection activity
JP3808632B2 (ja) * 1998-06-18 2006-08-16 富士通株式会社 光増幅器及び光増幅方法
GB9823835D0 (en) * 1998-10-30 1998-12-23 Univ London Component for vaccine
WO2000062815A2 (en) * 1999-04-15 2000-10-26 Glaxo Group Limited Novel pharmaceutical composition suitable for gene therapy
US6303573B1 (en) * 1999-06-07 2001-10-16 The Burnham Institute Heart homing peptides and methods of using same
CA2391348A1 (en) 1999-07-29 2001-02-08 Assem Ziady Enhanced delivery via serpin enzyme complex receptor
US6885683B1 (en) * 2000-05-23 2005-04-26 Imra America, Inc. Modular, high energy, widely-tunable ultrafast fiber source
US6507430B2 (en) * 2001-02-23 2003-01-14 Photon X, Inc. Long wavelength optical amplifier
KR100424630B1 (ko) * 2002-02-14 2004-03-25 삼성전자주식회사 엘-밴드 어븀첨가 광섬유 증폭기
GB2395353B (en) * 2002-02-18 2004-10-13 Univ Southampton Pulsed light sources
US6990270B2 (en) * 2004-02-11 2006-01-24 Fitel U.S.A. Corp. Fiber amplifier for generating femtosecond pulses in single mode fiber

Similar Documents

Publication Publication Date Title
BE2019C547I2 (ja)
BE2019C510I2 (ja)
BE2018C021I2 (ja)
BE2017C049I2 (ja)
BE2017C005I2 (ja)
BE2016C069I2 (ja)
BE2016C040I2 (ja)
BE2016C013I2 (ja)
BE2018C018I2 (ja)
BE2016C002I2 (ja)
BE2015C078I2 (ja)
BE2015C017I2 (ja)
BE2014C053I2 (ja)
BE2014C051I2 (ja)
BE2014C041I2 (ja)
BE2014C030I2 (ja)
BE2014C016I2 (ja)
BE2014C015I2 (ja)
BE2013C063I2 (ja)
BE2013C039I2 (ja)
BE2011C038I2 (ja)
BRPI0302144B1 (ja)
JP2003245457A5 (ja)
BRPI0215435A2 (ja)
BE2013C046I2 (ja)